The Centre has stepped up regulatory surveillance on GLP-1-based weight-loss drugs amid rising concerns over misuse, with enforcement expected to impact pharmacies, clinics, and online platforms in Guwahati.
According to the Ministry of Health and Family Welfare, the Drugs Controller General of India (DCGI) has intensified oversight across the pharmaceutical supply chain following the entry of multiple generic versions of these drugs into the Indian market.
The Indian government has tightened surveillance on GLP-1 weight-loss drugs to prevent misuse and illegal sales. In Guwahati, pharmacies, clinics, and online sellers may face stricter checks as authorities act against unauthorised distribution and misleading promotion.
Why Action Has Been Taken
Health authorities have raised concerns that these drugs are increasingly being:
- Sold without valid prescriptions
- Promoted as quick weight-loss solutions
- Used without medical supervision
The ministry warned that such misuse can lead to serious health risks and adverse effects.
What Are GLP-1 Drugs?
GLP-1 receptor agonists, including semaglutide, are primarily used for:
- Managing Type 2 diabetes
- Regulating blood sugar levels
- Controlling appetite and weight
Originally developed for diabetes treatment, these drugs have gained popularity for weight loss.
The patent for semaglutide expired on March 21, 2026, leading to the launch of cheaper generic versions, with price reductions of up to 70–90%.
Increased Monitoring and Inspections
Authorities have intensified enforcement across India, including cities like Guwahati:
- 49 entities inspected, including pharmacies and wellness clinics
- Monitoring of online pharmacy warehouses and sellers
- An advisory was issued to manufacturers banning misleading promotions
The government has also prohibited surrogate advertising and indirect marketing that could mislead consumers.
What It Means for Guwahati
In Guwahati, where private clinics, pharmacies, and online medicine platforms are widely used, the move could lead to:
- Stricter prescription checks at pharmacies
- Increased scrutiny of wellness and slimming clinics
- Reduced availability of drugs without proper consultation
Residents are being advised to avoid self-medication and seek guidance from qualified doctors.
What Happens Next
Regulatory authorities are expected to continue inspections and enforcement to ensure compliance.
In Guwahati, pharmacies and clinics may face tighter monitoring in the coming weeks as part of the nationwide crackdown.
Frequently Asked Questions
Q1. What are GLP-1 weight-loss drugs?
They are medicines used to manage diabetes and weight by controlling appetite and blood sugar levels.
Q2. Why is the government taking action?
To prevent misuse, illegal sales, and misleading promotion of these drugs.
Q3. How will this affect Guwahati?
Pharmacies and clinics may face stricter checks, and users may need proper prescriptions to access such medications.